<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput xmlns:ns2="local" hits="1" offset="0" totalResults="1"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="0"></Filter><Filter label="Indications" name="indications" total="1"><FilterOption id="238" count="1" label="Obesity"></FilterOption></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="14"><FilterOption id="20401" count="1" label="Obesity - Anthropometric Assessments - Assessment of weight loss"></FilterOption><FilterOption id="20554" count="1" label="Obesity - Assessment of Cardiac Function - Assessment of blood pressure"></FilterOption><FilterOption id="20428" count="1" label="Obesity - Assessment of Dietary Intake - Assessment of caloric intake"></FilterOption><FilterOption id="20431" count="1" label="Obesity - Assessment of Dietary Intake - Assessment of eating pattern"></FilterOption><FilterOption id="20625" count="1" label="Obesity - Assessment of Neuropsychological Function - Assessment of cognitive function"></FilterOption><FilterOption id="20653" count="1" label="Obesity - Assessment of Physical Examination"></FilterOption><FilterOption id="20714" count="1" label="Obesity - Assessment of Pulmonary Function - Assessment of pulmonary function test"></FilterOption><FilterOption id="20456" count="1" label="Obesity - Assessment of lipid profiles - Assessment of HDL"></FilterOption><FilterOption id="20455" count="1" label="Obesity - Assessment of lipid profiles - Assessment of LDL-C"></FilterOption><FilterOption id="20452" count="1" label="Obesity - Assessment of lipid profiles - Assessment of Triglycerides"></FilterOption><FilterOption id="20458" count="1" label="Obesity - Assessment of lipid profiles - Assessment of cholesterol"></FilterOption><FilterOption id="20433" count="1" label="Obesity - Glycemic Control Analysis - Assessment of blood glucose"></FilterOption><FilterOption id="29704" count="1" label="Obesity - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Health Related Quality of Life (HRQOL)"></FilterOption><FilterOption id="29762" count="1" label="Obesity - Patient Reported Outcomes/Quality of Life Assessments - Quality of life(Non-specific)"></FilterOption></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="0"></Filter><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="1"><FilterOption id="1103245" count="1" label="Klinik Blankenstein"></FilterOption></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="1"><FilterOption id="4" count="1" label="Completed"></FilterOption></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="1"><FilterOption id="NO" count="1" label="No"></FilterOption></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="0"></Filter><Filter label="Registry Id" name="trialRegistries" total="2"><FilterOption id="1019" count="1" label="DRKS"></FilterOption><FilterOption id="1004" count="1" label="WHO ICTRP"></FilterOption></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="0"></Filter><Filter label="Active Controls" name="trialActiveControls" total="0"></Filter><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="14"><FilterOption id="15382" count="1" label="Obesity - Protocol Specified Other Exclusion Criteria - Any medical/surgical condition interfering with participation in the study"></FilterOption><FilterOption id="15368" count="1" label="Obesity - Protocol Specified Other Exclusion Criteria - Prior/Recent participating in clinical trial"></FilterOption><FilterOption id="15392" count="1" label="Obesity - Protocol Specified Other Exclusion Criteria - Subjects with history of/planned surgery"></FilterOption><FilterOption id="15312" count="1" label="Obesity - Subjects co-morbid with Endocrine/Metabolic Disorders - Subjects co-morbid with diabetes mellitus"></FilterOption><FilterOption id="15313" count="1" label="Obesity - Subjects co-morbid with Endocrine/Metabolic Disorders - Subjects with thyroid disorders"></FilterOption><FilterOption id="15296" count="1" label="Obesity - Subjects co-morbid with Psychiatric Disease/Disorder - Subjects with eating disorders"></FilterOption><FilterOption id="15321" count="1" label="Obesity - Subjects co-morbid with cardiovascular diseases/disorders - Subjects co-morbid with coronary artery disease"></FilterOption><FilterOption id="15309" count="1" label="Obesity - Subjects co-morbid with gastrointestinal diseases/disorders"></FilterOption><FilterOption id="15310" count="1" label="Obesity - Subjects co-morbid with hepatobiliary disorders/diseases"></FilterOption><FilterOption id="15299" count="1" label="Obesity - Subjects co-morbid with renal disease/disorder"></FilterOption><FilterOption id="15331" count="1" label="Obesity - Subjects with Co-morbid Conditions - Subjects with neoplasm/malignancy"></FilterOption><FilterOption id="15335" count="1" label="Obesity - Subjects with History of Surgical Procedures for Weight Loss"></FilterOption><FilterOption id="15411" count="1" label="Obesity - Subjects with History of/Scheduled to Receive Therapy - Subjects on/treated with weight loss medications"></FilterOption><FilterOption id="15397" count="1" label="Obesity - Subjects with Protocol Specified Reproductive Status - Pregnancy/Lactation/Women of childbearing potential/Intend to become pregnant/Without adequate contraception"></FilterOption></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="0"></Filter><Filter label="Funder Type" name="trialFunderType" total="1"><FilterOption id="CMP" count="1" label="Company"></FilterOption></Filter><Filter label="Trial Region" name="trialRegions" total="1"><FilterOption id="NSWE" count="1" label="Northern, Southern &amp; Western Europe"></FilterOption></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="1"><FilterOption id="7733" count="1" label="Obesity - Overweight (pre-obese) Subjects"></FilterOption></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="0"></Filter><Filter label="Trial Country" name="trialCountries" total="1"><FilterOption id="DE" count="1" label="Germany"></FilterOption></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="3"><FilterOption id="EAAAD" count="1" label="Aged Adults (65-79 yrs)"></FilterOption><FilterOption id="EAMAA" count="1" label="Middle-aged Adults (45-64 yrs)"></FilterOption><FilterOption id="EAYAD" count="1" label="Young Adults (18-44 yrs)"></FilterOption></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="6"><FilterOption id="SICACT" count="1" label="Active Control"></FilterOption><FilterOption id="SSTINV" count="1" label="Interventional"></FilterOption><FilterOption id="SIANON" count="1" label="Non-Randomized"></FilterOption><FilterOption id="SIMOPN" count="1" label="Open Label"></FilterOption><FilterOption id="SISPRL" count="1" label="Parallel Assignment"></FilterOption><FilterOption id="SIPTRE" count="1" label="Treatment"></FilterOption></Filter><Filter label="Trial Source" name="trialSources" total="0"></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="0"></Filter><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="0"></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="12"><FilterOption id="20401" count="1" label="Obesity - Anthropometric Assessments - Assessment of weight loss"></FilterOption><FilterOption id="20554" count="1" label="Obesity - Assessment of Cardiac Function - Assessment of blood pressure"></FilterOption><FilterOption id="20431" count="1" label="Obesity - Assessment of Dietary Intake - Assessment of eating pattern"></FilterOption><FilterOption id="20625" count="1" label="Obesity - Assessment of Neuropsychological Function - Assessment of cognitive function"></FilterOption><FilterOption id="20653" count="1" label="Obesity - Assessment of Physical Examination"></FilterOption><FilterOption id="20714" count="1" label="Obesity - Assessment of Pulmonary Function - Assessment of pulmonary function test"></FilterOption><FilterOption id="20456" count="1" label="Obesity - Assessment of lipid profiles - Assessment of HDL"></FilterOption><FilterOption id="20455" count="1" label="Obesity - Assessment of lipid profiles - Assessment of LDL-C"></FilterOption><FilterOption id="20452" count="1" label="Obesity - Assessment of lipid profiles - Assessment of Triglycerides"></FilterOption><FilterOption id="20458" count="1" label="Obesity - Assessment of lipid profiles - Assessment of cholesterol"></FilterOption><FilterOption id="20433" count="1" label="Obesity - Glycemic Control Analysis - Assessment of blood glucose"></FilterOption><FilterOption id="29762" count="1" label="Obesity - Patient Reported Outcomes/Quality of Life Assessments - Quality of life(Non-specific)"></FilterOption></Filter><Filter label="Biomarker" name="trialBiomarkerNames" total="6"><FilterOption id="2586" count="1" label="Blood pressure"></FilterOption><FilterOption id="1735" count="1" label="Glucose"></FilterOption><FilterOption id="153" count="1" label="High-density lipoprotein cholesterol"></FilterOption><FilterOption id="152" count="1" label="Low-density lipoprotein cholesterol"></FilterOption><FilterOption id="12058" count="1" label="Total body mass"></FilterOption><FilterOption id="217" count="1" label="Triglycerides"></FilterOption></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="0"></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="0"></Filter><Filter label="Trial Document Source" name="trialDocumentSource" total="0"></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="0"></Filter><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="0"></Filter><Filter label="Trial Category" name="trialCategory" total="1"><FilterOption id="11" count="1" label="Dietary supplement"></FilterOption></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="1"><FilterOption id="NO" count="1" label="No"></FilterOption></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="0"></Filter><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="0"></Filter><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="0"></Filter><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="3"><FilterOption id="39" count="1" label="Anthropomorphic"></FilterOption><FilterOption id="32" count="1" label="Biochemical"></FilterOption><FilterOption id="31" count="1" label="Physiological"></FilterOption></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="1"><FilterOption id="695863716" count="1" label="Therapeutic effect marker"></FilterOption></Filter><Filter label="Interventions" name="trialInterventions" total="0"></Filter><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="1"><FilterOption id="20401" count="1" label="Obesity - Anthropometric Assessments - Assessment of weight loss"></FilterOption></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="1"><FilterOption id="1103245" count="1" label="Klinik Blankenstein"></FilterOption></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="1"><FilterOption count="1" label="2018-01-25"></FilterOption></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="1"><FilterOption count="1" label="200808"></FilterOption></Filter><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="1"><FilterOption count="1" label="200708"></FilterOption></Filter><Filter label="Trial Phase" name="trialPhase" total="1"><FilterOption id="NS" count="1" label="Phase not specified"></FilterOption></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="7"><FilterOption id="19672" count="1" label="Obesity - Obese Subjects"></FilterOption><FilterOption id="19759" count="1" label="Obesity - Subjects with History of/Scheduled to Receive Therapy"></FilterOption><FilterOption id="22428" count="1" label="Obesity - Subjects with Protocol Specified Anthropometric Measurements - Overweight Subjects"></FilterOption><FilterOption id="19680" count="1" label="Obesity - Subjects with Protocol Specified BMI - Subjects with BMI&gt;25"></FilterOption><FilterOption id="19681" count="1" label="Obesity - Subjects with Protocol Specified BMI - Subjects with BMI&gt;27"></FilterOption><FilterOption id="19682" count="1" label="Obesity - Subjects with Protocol Specified BMI - Subjects with BMI&gt;30"></FilterOption><FilterOption id="19791" count="1" label="Obesity - Subjects with Protocol Specified Participation Status - Subjects with compliance to informed consent process"></FilterOption></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="0"></Filter><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="0"></Filter><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="0"></Filter></Filters><SearchResults><Trial Id="216588"><Indications><Indication>Obesity</Indication></Indications><CompaniesSponsor><Company>Klinik Blankenstein</Company></CompaniesSponsor><Countries><Country>Germany</Country></Countries><DateChangeLast>2018-01-25T00:00:00Z</DateChangeLast><DateEnd>2008-08-31T00:00:00Z</DateEnd><DateStart>2007-08-13T00:00:00Z</DateStart><Identifiers><Identifier>2977</Identifier><Identifier>DRKS00006343</Identifier><Identifier>U1111-1159-2725</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>Fasting therapy modified according to Buchinger alone</Intervention><Intervention>Weight reduction diet alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>68</PatientCountEnrollment><Phase>Phase not specified</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>This study examines the course of health over 6 months after inpatient naturopathic fasting therapy in overweight or obese patients compared to patients with a low-caloric balanced diet. Eating behavior, health-associated quality of life and physical activity of the patients were examined. These parameters were recorded at the beginning, in the middle and at the end of the inpatient therapy as well as during the follow-up period after 3 and 6 months.</Teaser><TrialCategories><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Non-Randomized</Term><Term>Open Label</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><EndpointIndex><EndpointIndex>Obesity - Anthropometric Assessments - Assessment of weight loss</EndpointIndex><EndpointIndex>Obesity - Assessment of Cardiac Function - Assessment of blood pressure</EndpointIndex><EndpointIndex>Obesity - Assessment of Dietary Intake - Assessment of caloric intake</EndpointIndex><EndpointIndex>Obesity - Assessment of Dietary Intake - Assessment of eating pattern</EndpointIndex><EndpointIndex>Obesity - Assessment of Neuropsychological Function - Assessment of cognitive function</EndpointIndex><EndpointIndex>Obesity - Assessment of Physical Examination</EndpointIndex><EndpointIndex>Obesity - Assessment of Pulmonary Function - Assessment of pulmonary function test</EndpointIndex><EndpointIndex>Obesity - Assessment of lipid profiles - Assessment of HDL</EndpointIndex><EndpointIndex>Obesity - Assessment of lipid profiles - Assessment of LDL-C</EndpointIndex><EndpointIndex>Obesity - Assessment of lipid profiles - Assessment of Triglycerides</EndpointIndex><EndpointIndex>Obesity - Assessment of lipid profiles - Assessment of cholesterol</EndpointIndex><EndpointIndex>Obesity - Glycemic Control Analysis - Assessment of blood glucose</EndpointIndex><EndpointIndex>Obesity - Patient Reported Outcomes/Quality of Life Assessments - Assessment by Health Related Quality of Life (HRQOL)</EndpointIndex><EndpointIndex>Obesity - Patient Reported Outcomes/Quality of Life Assessments - Quality of life(Non-specific)</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term></TermsPatientSelection><TitleDisplay>Controlled prospective study to evaluate the inpatient naturopathic fasting therapy in overweight and obese patients</TitleDisplay><PatientSegmentTerms><PatientSegment>Obesity - Overweight (pre-obese) Subjects</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Blood pressure </BiomarkerName><BiomarkerName> Glucose </BiomarkerName><BiomarkerName> High-density lipoprotein cholesterol </BiomarkerName><BiomarkerName> Low-density lipoprotein cholesterol </BiomarkerName><BiomarkerName> Total body mass </BiomarkerName><BiomarkerName> Triglycerides</BiomarkerName></BiomarkerNames><PrimaryCompletionDate></PrimaryCompletionDate><TrialDuration>12 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>André-Michael Beer</Name></ContactNames></Trial></SearchResults></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput>